Patents by Inventor Longen Zhou

Longen Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions containing an indoyl isoquinoline containing compound and uses thereof
    Patent number: 9012455
    Abstract: Chronic myelogenous leukemia (CML), and in particular imatinib resistant CML is treated using compositions and methods in which a Rad51-inhibitor and a kinase inhibitor are administered. Most preferably, the Rad51 inhibitor comprises an indolyl isoquinoline structure and the kinase inhibitor is a BCR-ABL inhibitor.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: April 21, 2015
    Assignee: The Regents of the University of California
    Inventors: Wen-Hwa Lee, Phang-Lang Chen, Longen Zhou, Jiewen Zhu
  • Compositions and Methods Related to RAD51 Inactivation in the Treatment of Neoplastic Diseases, and Especially CML
    Publication number: 20090312324
    Abstract: Chronic myelogenous leukemia (CML), and in particular imatinib resistant CML is treated using compositions and methods in which a Rad51-inhibitor and a kinase inhibitor are administered. Most preferably, the Rad51 inhibitor comprises an indolyl isoquinoline structure and the kinase inhibitor is a BCR-ABL inhibitor.
    Type: Application
    Filed: April 10, 2007
    Publication date: December 17, 2009
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Wen-Hwa Lee, Phang-Lang Chen, Longen Zhou, Jiewen Zhu